ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.12 -0.19 (-4.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Depreciation & Amortization (CF) (2020 - 2026)

Updated

ARS Pharmaceuticals' Depreciation & Amortization (CF) was $416,000 in Q2 2026, up 49.1% from $279,000 a year earlier and up 4.8% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, ARS Pharmaceuticals' Depreciation & Amortization (CF) was $1.62 million through Jun 30, 2026, up 135.6% year-over-year; for FY2025, it came in at $1.37 million.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $79,000 in FY2024 (-21.0%), $100,000 in FY2023 (unchanged), $100,000 in FY2022 (-53.1%) and $213,000 in FY2021 (-66.6%).
  • Quarterly Depreciation & Amortization (CF) has moved between -$37,000 (Q2 2022) and $417,000 (Q4 2025) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in three of the last four quarters, with growth averaging 95.5%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2025 (growth of 291.0%); the worst was Q3 2022 (a decline of 96.5%).
  • Per Business Quant data, SPRY's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $397,000 (Q1 2026), $417,000 (Q4 2025) and $391,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 ARS Pharmaceuticals 428.58 Mn 284.78 Mn 20.81 Mn 416,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 416,000.00
Mar 31, 2026 397,000.00
Dec 31, 2025 417,000.00
Sep 30, 2025 391,000.00
Jun 30, 2025 279,000.00
Mar 31, 2025 280,000.00
Dec 31, 2024 29,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 18,000.00
Mar 31, 2024 11,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 20,000.00
Mar 31, 2023 20,000.00
Dec 31, 2022 14,000.00
Sep 30, 2022 7,000.00
Jun 30, 2022 -37,000.00
Mar 31, 2022 207,000.00
Dec 31, 2021 204,000.00
Sep 30, 2021 201,000.00
Jun 30, 2021 209,000.00
API Access

ARS Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SPRY&period=max&api_key=YOUR_API_KEY